# Element Solutions Inc: Form 10-Q for the period ended Mar 31, 2016

- Company: [Element Solutions Inc](/companies/esi.md) (CIK 1590714)
- Form: 10-Q
- Filed: 2016-05-10
- Accepted by EDGAR: May 9, 2016, 18:49 ET
- Period: 2016-03-31
- Accession: 0001590714-16-000153
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1590714/000159071416000153/pah10-q2016331document.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1590714/000159071416000153/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-01-01 to 2016-03-31 | $823.8m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2016-01-01 to 2016-03-31 | $467.8m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2016-01-01 to 2016-03-31 | $356.0m | us-gaap:GrossProfit |
| Research and development | 3 months, 2016-01-01 to 2016-03-31 | $19.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2016-01-01 to 2016-03-31 | $284.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2016-01-01 to 2016-03-31 | $52.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2016-01-01 to 2016-03-31 | $18.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-01-01 to 2016-03-31 | −$134.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2016-01-01 to 2016-03-31 | −$0.59 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2016-01-01 to 2016-03-31 | −$0.59 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2016-01-01 to 2016-03-31 | 229,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2016-01-01 to 2016-03-31 | −$210.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2016-01-01 to 2016-03-31 | $11.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2016-03-31 | $329.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-03-31 | $2.30bn | us-gaap:AssetsCurrent |
| Total assets | at 2016-03-31 | $10.59bn | us-gaap:Assets |
| Current liabilities | at 2016-03-31 | $1.18bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2016-03-31 | $7.50bn | us-gaap:Liabilities |
| Long-term debt | at 2016-03-31 | $5.22bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2016-03-31 | $188.9m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2016-03-31 | $149.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2016-03-31 | $2.27bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 62,110 characters.

### Forward-Looking Information

*From time to time, Platform may make or publish forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect Platform’s current views with respect to, among other things, future events and performance. These statements may discuss, among other things, Platform’s financial or operational results including earnings guidance, future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects; business and management strategies; and the effects of global economic conditions on Platform’s business. Platform generally identifies forward-looking statements by words such as “plans,” “expects,” “is expected,” “is subject to,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates,” “believes,” “targets,” “aims,” “projects” or words or terms of similar substance or the negative thereof, as well as variations of such words and phrases or statements that certain actions, events or results “may,” “could,” “should,” “would,” “might” or “will” be taken, occur or be achieved. Forward-looking statements are based on beliefs and assumptions made by management using currently available information. These statements are only predictions and are not guarantees of future performance, actions or events. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management’s underlying beliefs and assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Factors that can cause actual results to differ materially from those reflected in the forward-looking statements include, among others, those discussed in Part I, Item 1A of Platform's Annual Report under the heading "Risk Factors," and elsewhere in this Quarterly Report. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties, and we urge you not to place undue reliance on any forward looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Also, historical results are not necessarily indicative of the results expected for any future period. You are advised to consult any further disclosures we make on related subjects in the Company’s Form 10-K, 10-Q and 8-K reports filed with the SEC.*

*The following “Executive Overview” section is a brief summary of the significant items addressed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations. Investors should read the relevant portions of this section for a complete discussion of the items summarized below.*

### Executive Overview

We are a global, diversified producer of high-technology specialty chemical products. Our business involves the formulation of a broad range of solutions-oriented specialty chemicals, which are sold into multiple industries, including agricultural, animal health, electronics, graphic arts, plating, and offshore oil and gas production and drilling. We refer to our products as “dynamic chemistries” due to their intricate chemical compositions. Our dynamic chemistries are used in a wide variety of attractive niche markets and we believe that the majority of our operations hold strong positions in the product markets they serve.

Our strategy is to acquire and maintain leading positions in niche sectors of high-growth markets. As our name “Platform Specialty Products Corporation” implies, we continually seek opportunities to act as an acquirer and consolidator of specialty chemical businesses on a global basis, particularly those meeting our “Asset-Lite, High-Touch” philosophy, which involves prioritizing extensive resources to research and development and highly technical customer service, while managing conservatively our investments in fixed assets and capital expenditures. We regularly review acquisition opportunities and may acquire businesses that meet our acquisition criteria when we deem it to be financially and fiscally prudent. To date, we have completed seven acquisitions: the MacDermid Acquisition on October 31, 2013, the Agriphar Acquisition on October 1, 2014, the CAS Acquisition on November 3, 2014, the Arysta Acquisition on February 13, 2015, the OMG Acquisition on October 28, 2015, the Alent Acquisition on December 1, 2015 and the OMG Malaysia Acquisition on January 31, 2016.

We generate revenue through the formulation and sale of our dynamic chemistries and by providing highly-technical services to our customers through our extensive global network of specially trained service personnel. Our personnel work closely with our customers to ensure that the intricate chemical composition and function of our products are maintained as intended while ensuring that these products are applied safely and effectively by users globally.

We believe that the fragmented nature of the specialty chemical products market will continue to provide significant opportunities for growth. We also believe that our combined company provides a strong platform on which to grow our business and expand our market shares in key geographic markets, particularly in emerging markets. We expect that the Acquisitions will enhance our growth by extending our products breadth, developing higher-margin products and growing internationally. We intend to extend many of our product offerings through the development of new applications for our existing products or through synergistic combinations. Our goal is to target those geographies with attractive market fundamentals where our strengths in marketing, portfolio development, registration and customer education can add value for our customers.

As previously disclosed in our Annual Report, in connection with the implementation of internal controls at Arysta, a newly acquired subsidiary, we discovered certain payments made to third-party agents in connection with Arysta’s government tender business in West Africa which may be illegal or otherwise inappropriate. We have engaged outside counsel and an outside accounting firm to conduct an internal investigation to review the legality of these and other payments made in Arysta’s West Africa tender business, including Arysta’s compliance with the FCPA. We contacted the SEC and the U.S. Department of Justice to voluntarily inform them of this matter and we are fully cooperating with these governmental authorities as the investigation continues and as they review the matter. Although the internal investigation is still ongoing at the time of this Quarterly Report, based on the results to date, management does not currently believe that the amount of the payments in question, or any revenue or operating income related to those payments, are material to our business, results of operations, financial condition or liquidity.

As previously disclosed in our quarterly report on Form 10-Q for the quarter ended June 30, 2015, an error to goodwill and foreign currency translation adjustment of $72.8 million occurred relating to the Arysta Acquisition and was corrected as an out-of-period adjustment in such quarterly report. We subsequently concluded that this previously disclosed error also had the effect of understating cash flows provided by operating activities and cash flows used in investing activities by $72.8 million, and therefore further concluded that the previously reported information should no longer be relied upon. As a result, we restated our unaudited Condensed Consolidated Statement of Comprehensive Income, Condensed Consolidated Balance Sheet, Condensed Consolidated Statement of Cash Flows, Condensed Consolidated Statement of Changes in Stockholders' Equity and related notes, for and as of the three months ended March 31, 2015. This restatement is included in Note 20, *Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Unaudited)* to the unaudited interim Condensed Consolidated Financial Statements included herein. The error had no impact on the net decrease in cash and cash equivalents for the quarter ended March 31, 2015 and cash balances as of March 31, 2015. Further, the restatement does not impact our quarterly reports on Form 10-Q for the quarters ended June 30, 2015 and September 30, 2015, our Annual Report or our adjusted EBITDA or pro forma adjusted earnings per share, both non-U.S. GAAP measures, as previously reported in Platform's earnings release issued on May 12, 2015 and subsequent earnings releases for the remainder of 2015.

### Non-U.S. GAAP Financial Measures

In this Management’s Discussion and Analysis of Financial Condition and Results of Operations section, we present certain financial measures related to our business that are “non-U.S. GAAP financial measures” within the meaning of Item 10 of Regulation S-K. Such non-U.S. GAAP financial measures include adjusted net sales change, adjusted cost of sales change, adjusted gross profit change, adjusted selling, technical, general and administrative expense change, adjusted research and development expense change and adjusted operating profit change, in each case adjusted for the Acquisitions for all periods presented and foreign currency translations. We have presented both U.S. GAAP and adjusted financial information to better provide investors with measures that allow them to more readily compare our performance, including, among other things, giving investors additional information regarding our organic performance without giving effect to the Acquisitions and the impact of translating foreign currencies into U.S. Dollars and the impact of currency rate changes on foreign currency denominated transactions. However, these non-U.S. GAAP financial measures should be considered in addition to, and not a substitute for, the financial information that we report in accordance with U.S. GAAP.

### Acquisitions

#### OMG Malaysia Acquisition

On January 31, 2016, we completed the OMG Malaysia Acquisition for approximately $124 million, net of acquired cash and closing working capital adjustments, subject to purchase price adjustments.

We financed the OMG Malaysia Acquisition with the proceeds from the June 2015 Equity Offering.

#### Alent Acquisition

On December 1, 2015, we completed the Alent Acquisition by acquiring all the issued shares of Alent for approximately $1.74 billion in cash, net of acquired cash, and 18,419,738 shares of our common stock issued to Alent shareholders, including Cevian Capital II Master Fund LP, the then largest shareholder of Alent.

We financed the Alent Acquisition with (i) available cash on hand, (ii) the proceeds from the November 2015 Notes Offering of $500 million aggregate principal amount of 10.375% USD Notes due 2021, and (iii) additional borrowings of $1.05 billion (less original issue discount of 2%) through the establishment of the Alent U.S. Dollar Tranche B-3 Term Loan, approximately €300 million (less original discount of 2%) through the establishment of the Alent EURO Tranche C-2 Term Loan, and $115 million under our increased U.S. Dollar Revolving Credit Facility.

#### OMG Acquisition

On October 28, 2015, we completed the OMG Acquisition for a total purchase price of approximately $239 million in cash, net of acquired cash, subject to purchase price adjustments.

We financed the OMG Acquisition with the proceeds from the June 2015 Equity Offering.

#### Arysta Acquisition

On February 13, 2015, we completed the Arysta Acquisition for approximately $3.50 billion. The purchase price consisted of $2.86 billion in cash (net of acquired cash, closing adjustments and including Arysta Seller transaction expenses paid by Platform) and $600 million of Platform's Series B Convertible Preferred Stock issued to the Arysta Seller with a fair market value of $646 million.

We financed the Arysta Acquisition with the proceeds from (1) available cash on hand, (2) the offering of $1.10 billion aggregate principal amount of 6.50% USD Notes due 2022 denominated in U.S. Dollars and €350 million aggregate principal amount of 6.00% EUR Notes due 2023 denominated in Euros (plus original issue premium of $1.0 million), which offering was completed on February 2, 2015, and (3) additional borrowings of $500 million (less original issue discount of 1%) through an incremental term loan denominated in U.S. Dollars, €83 million (less original discount of 2%) through an increase to our existing term loan facility denominated in Euros, and an additional $160 million under our U.S. Dollar Revolving Credit Facility.

#### CAS Acquisition

On November 3, 2014, we completed the CAS Acquisition for $1.04 billion, consisting of $983 million in cash, net of acquired cash and certain post-closing working capital and other adjustments, and 2,000,000 shares of our common stock.

We financed the CAS Acquisition with a combination of available cash on hand and borrowings under an increase in term loans of approximately $389 million ($256 million of which is denominated in Euros), $60 million under our U.S. Dollar Revolving Credit Facility and €55 million ($68.7 million) under our multicurrency Revolving Credit Facility pursuant to our Amended and Restated Credit Agreement.

#### Agriphar Acquisition

On October 1, 2014, we completed the Agriphar Acquisition for approximately €300 million ($370 million) consisting of $350 million in cash, net of acquired cash and certain post-closing working capital and other adjustments, and 711,551 restricted shares of our common stock.

We financed the Agriphar Acquisition with proceeds from the Incremental Amendment and available cash on hand.

#### MacDermid Acquisition

On October 31, 2013, we completed the MacDermid Acquisition, pursuant to which we indirectly acquired substantially all of the equity of MacDermid Holdings which, at the time, owned 97% of MacDermid. As a result, we became a holding company for the MacDermid business. We acquired the remaining 3% of MacDermid on March 4, 2014, pursuant to the terms of an Exchange Agreement, dated October 25, 2013, between us and the fiduciaries of the 401K Plan. Concurrently with the closing of the MacDermid Acquisition, we changed our name to “Platform Specialty Products Corporation.” On January 22, 2014, we completed the Domestication, changing our jurisdiction of incorporation from the British Virgin Islands to Delaware, and on January 23, 2014, our common stock began trading on the NYSE under the ticker symbol “PAH.”

The total consideration for the MacDermid Acquisition and the Exchange Agreement was approximately $1.80 billion (including the assumption of $754 million of indebtedness, consisting primarily of MacDermid’s then first lien credit facility), plus (i) up to $100 million of contingent consideration tied to achieving certain EBITDA and stock trading price performance metrics over a seven-year period following the closing of the MacDermid Acquisition and (ii) an interest in certain MacDermid pending litigation which consideration was paid through a combination of both equity interests and cash.

### Our Business

We generate revenue through the formulation and sale of our dynamic chemistries to our customers through our extensive global network of specially trained service personnel. Our personnel work closely with our customers to ensure that the chemical composition and function of our dynamic chemistries are maintained as intended.

While our dynamic chemistries typically represent only a small portion of our customers’ costs, we believe that they are critical to our customers’ manufacturing processes and overall product performance. Further, operational risks and switching costs make it difficult for our customers to change suppliers and allow us to retain customers and maintain our market positions.

### Business Segments

Our operations are organized into two reportable segments: Performance Solutions and Agricultural Solutions. The reporting segments represent businesses for which separate financial information is utilized by the chief operating decision maker, or CODM, for purpose of allocating resources and evaluating performance. Each of the reportable segments has its own president, who reports to the CODM.

#### Performance Solutions

Our Performance Solutions segment formulates and markets dynamic chemistry solutions that are used in electronics, automotive production, oil and gas production, drilling, and commercial packaging and printing. Our products include surface and coating materials, functional convention coatings, electronic assembly materials, water-based hydraulic control fluids and photopolymers. In conjunction with the sale of these products, we provide extensive technical service and support when necessary to ensure superior performance of their application. Within this segment, we provide specialty chemicals to the following industries: Electronics, Electronics Assembly Materials, Industrial, Offshore and Commercial Packing and Printing. For the Electronics industry, we design and formulate a complete line of proprietary “wet” dynamic chemistries that our customers use to process the surface of printed circuit boards and other electronic components they manufacture. For the Electronics Assembly Materials industry, we develop, manufacture and sell innovative interconnected materials, primarily in the electronics market, used to assemble printed circuit boards and advanced semiconductor packaging. We also offer a small water treatment product line. For the Industrial industry, our dynamic chemistries are used for finishing, cleaning and providing surface coatings for a broad range of metal and non-metal surfaces which improve the performance or look of a component of an industrial part or process. For the Offshore industry, we produce water-based hydraulic control fluids for major oil and gas companies and drilling contractors for offshore deep water production and drilling applications. For the Commercial Packaging and Printing industries, we produce photopolymers through an extensive line of flexographic plates, used to produce printing plates for transferring images onto commercial packaging, including packaging for consumer food products, pet food bags, corrugated boxes, labels and beverage containers. In addition, we also produce photopolymer printing plates for the flexographic and letterpress newspaper and publications markets.

#### Agricultural Solutions

Our Agricultural Solutions segment is based on a solutions-oriented business model that focuses on product innovation to address an ever-increasing need for higher crop yield and quality. We offer to growers diverse crop protection solutions from weeds (herbicides), insects (insecticides) and diseases (fungicides), in foliar and seed treatment applications. We also offer a wide variety of proven biosolutions, including biostimulants, which stimulate plant growth and reproductive development, innovative nutrition, which optimizes the nutrition of plants, and biocontrol products, such as bioinsecticides and biofungicides, which perform the same task as conventional crop protection products without chemical residues. We emphasize farmer economics and food safety by combining, when possible, biosolutions with crop protection and seed treatment agrochemicals. Our Global Value Added Portfolio, or GVAP, consists of agrochemicals in the herbicides, insecticides, fungicides and seed treatment categories, based on patented or proprietary off-patent AIs. Our Global BioSolutions Portfolio, or GBP, includes biostimulants, innovative nutrition and biocontrol products. In addition, we offer regional off-patent AIs and certain non-crop products, including animal health products, such as honey bee protective miticides and certain veterinary vaccines.

Our business segments include significant foreign operations. There are certain risks associated with our foreign operations. See Part I, Item 1A Risk Factors – “*Our substantial international operations subject us to risks not faced by domestic competitors”* included in our Annual Report.

We sell our products worldwide. Because our segments may utilize shared facilities and administrative resources and offer products that are distinct from one another, we make decisions about how to manage our operations by reference to each segment and not with respect to the underlying products or geographic regions that comprise each segment.

### Results of Operations

The following table summarizes the results of operations for the three months ended March 31, 2016 and 2015:

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 | 2015 |
| --- | ---: | ---: |
| Net sales | $823.8 | $534.8 |
| Cost of sales | 467.8 | 327.7 |
| **Gross profit** | 356.0 | 207.1 |
| Selling, technical, general and administrative | 284.0 | 192.0 |
| Research and development | 19.9 | 12.9 |
| **Operating profit** | 52.1 | 2.2 |
| Interest, net | (93.8) | (39.4) |
| Other (expense) income | (74.3) | 35.6 |
| Income tax expense | (18.4) | (24.7) |
| **Net loss** | $(134.4) | $(26.3) |

### Three months ended March 31, 2016 versus the three months ended March 31, 2015.

For comparability purposes, changes in net sales, cost of sales, gross profit, selling, technical, general and administrative expense, research and development expense and operating profit are being presented exclusive of the OMG Malaysia, Alent and OMG Acquisitions.

The adjustments were as follows:

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 |
| --- | ---: |
| Net sales | $252.4 |
| Cost of sales | 164.4 |
| Gross profit | 88.0 |
| Selling, technical, general and administrative | 70.7 |
| Research and development | 7.0 |
| Operating profit | 10.3 |

In addition, we have also adjusted net sales, cost of sales, gross profit, selling, technical, general and administrative expense, research and development expense and operating profit for changes in foreign currency translations. We believe that the effect of these adjustments provides a more meaningful basis of comparing our results on a year-over-year basis.

### Net Sales

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 | 2015 |
| --- | ---: | ---: |
| Net sales | $823.8 | $534.8 |

Net sales in the first quarter of 2016 totaled $824 million, representing an increase of $289 million, or 54.0%, as compared to the first quarter of 2015.

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 $ Change |
| --- | ---: |
| Change, adjusted for acquisitions and foreign currency translation | $76.3 |
| - Acquisitions | 252.4 |
| - Foreign Currency Translation | (39.7) |
| Total Change | $289.0 |

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, net sales increased by $76.3 million, or 14.3%.

Performance Solutions' net sales in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $175 million, representing a decrease of $5.7 million, or 3.2%, as compared to the first quarter of 2015. The decrease in net sales was driven by slowness in core electronics end-markets served correlated to reduced spending in China telecommunications infrastructure spending, decreases in the price of oil resulting in delay of project startups onshore and offshore alike and industry consolidation in graphic solutions space adversely impacting pricing on sheet photopolymer product offerings used in flexographic printing. The impact of oil prices mentioned above was twofold: (1) reduced demand for offshore production control and drilling fluids in addition to (2) reduced demand for plating chemistry sold into the supply chain for onshore oil production rigs and stripping/cleaning chemistry utilized in polyethylene terephthalate recycling.

Agricultural Solutions' net sales in the first quarter of 2016, adjusted for foreign currency translation, totaled $437 million, representing an increase of $82.0 million, as compared to the first quarter of 2015. The increase was principally due to the exclusion of 2015 sales prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, overall sales were relatively flat with lower volumes substantially offset by favorable pricing. The volume decline was driven by the divestitures in the fourth quarter of 2015 of Toyo Green Co. Ltd. and Toyo Maintenance Co. Ltd. and reduced demand in the North American market in light of lower farmer income. These declines were partially offset by a strong growth of biosolutions products as well as strong growth of our weed resistance management herbicides portfolio. Selling prices were higher than in the first quarter of 2015 predominantly in Africa, Europe and Latin America.

### Cost of Sales

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 | 2015 |
| --- | ---: | ---: |
| Cost of sales | $467.8 | $327.7 |

Cost of sales in the first quarter of 2016 totaled $468 million, or 56.8% of net sales, as compared to $328 million, or 61.3% of net sales, in the first quarter of 2015, representing an increase of $140 million.

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 $ Change |
| --- | ---: |
| Change, adjusted for acquisitions and foreign currency translation | $(2.8) |
| - Acquisitions | 164.4 |
| - Foreign Currency Translation | (21.5) |
| Total Change | $140.1 |

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, cost of sales decreased by $2.8 million, or 0.9%.

Performance Solutions' cost of sales in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $81.1 million, as compared to $86.2 million in the first quarter of 2015, representing a decrease of $5.1 million, or 5.9%. The decrease in cost of sales related primarily to lower adjusted sales volume in the first quarter of 2016 coupled with reduced raw material costs and a favorable shift in product mix, which yielded margin expansion for the segment of 1.3% over the comparative prior year period.

Agricultural Solutions' cost of sales in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $244 million, as compared to $242 million in the first quarter of 2015, representing an increase of $2.3 million. The increase included the impact of purchase accounting related to the step-up of inventory that was sold during the first quarter of 2015 of $36.1 million. Excluding the effect of purchase accounting, cost of sales increased by $38.4 million, largely as a result of the exclusion of 2015 cost of sales prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, cost of sales declined due to lower volumes, favorable raw material procurement trends related to integration activities, and a shift in product mix based on an increased focus on higher margin products.

### Gross Profit

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 | 2015 |
| --- | ---: | ---: |
| Gross profit | $356.0 | $207.1 |

Gross profit in the first quarter of 2016 totaled $356 million, or 43.2% of net sales, as compared to $207 million, or 38.7% of net sales, in the first quarter of 2015, representing an increase of $149 million.

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 $ Change |
| --- | ---: |
| Change, adjusted for acquisitions and foreign currency translation | $79.1 |
| - Acquisitions | 88.0 |
| - Foreign Currency Translation | (18.2) |
| Total Change | $148.9 |

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, gross profit increased $79.1 million, or 38.2%.

Performance Solutions' gross profit in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $93.6 million, as compared to $94.2 million in the first quarter of 2015, representing a decrease of $0.6 million, or 0.6%. The decrease in gross profit related to a decrease of $5.7 million in net sales was offset, in part, by a 1.3% of gross margin expansion on $175 million of sales for the three months ended March 31, 2016.

Agricultural Solutions' gross profit in the first quarter of 2016, adjusted for foreign currency translation, totaled $193 million, as compared to $113 million in the first quarter of 2015, representing an increase of $79.7 million. Excluding the effect of purchase accounting on inventory in the first quarter 2015, as noted above, gross profit increased by $43.6 million. The first quarter of 2016 was favorable to the first quarter of 2015 largely as a result of the exclusion of 2015 gross profit prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, gross profit was positively impacted by favorable selling prices, improved raw material procurement trends and product mix as result of our focus on proprietary products and more profitable growing niche markets.

### Selling, Technical, General and Administrative Expense

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 | 2015 |
| --- | ---: | ---: |
| Selling, technical, general and administrative | $284.0 | $192.0 |

Selling, technical, general and administrative expense in the first quarter of 2016 totaled $284 million, or 34.5% of net sales, as compared to $192.0 million, or 35.9% of net sales, in the first quarter of 2015, representing an increase of $92 million.

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 $ Change |
| --- | ---: |
| Change, adjusted for acquisitions and foreign currency translation | $34.0 |
| - Acquisitions | 70.7 |
| - Foreign Currency Translation | (12.7) |
| Total Change | $92.0 |

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, selling, technical, general and administrative expense increased by $34.0 million, or 17.7%. The increase was due in part to additional investments we are making in building our corporate infrastructure in support of the demands driven by our substantial growth, including increases in headcount and professional fees, partially offset by lower quarter-over-quarter acquisition-related cost.

Performance Solutions' selling, technical, general and administrative expense in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, was relatively flat in comparison to the prior year quarter totaling $55.3 million.

Agricultural Solutions' selling, technical, general and administrative expense in the first quarter of 2016, adjusted for foreign currency translation, totaled $127 million, as compared to $108 million in the first quarter of 2015, representing an increase of $18.9 million. The first quarter of 2016 was unfavorable to the first quarter of 2015 largely as a result of the exclusion of 2015 expense activity prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, related expenses in the first quarter of 2016 were lower compared to the first quarter of 2015 as a result of captured integration synergies and stronger control of spending.

### Research and Development Expense

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 | 2015 |
| --- | ---: | ---: |
| Research and development | $19.9 | $12.9 |

Research and development expense in the first quarter of 2016 totaled $19.9 million, or 2.4% of net sales, as compared to $12.9 million, or 2.4% of net sales, in the first quarter of 2015, representing an increase of $7.0 million.

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 $ Change |
| --- | ---: |
| Change, adjusted for acquisitions and foreign currency translation | $0.7 |
| - Acquisitions | 7.0 |
| - Foreign Currency Translation | (0.7) |
| Total Change | $7.0 |

47

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, research and development expense increased by $0.7 million, or 5.4%.

Performance Solutions' research and development expense in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $5.2 million, as compared to $5.7 million in the first quarter of 2015, representing a decrease of $0.5 million, or 8.8%.

Agricultural Solutions' research and development expense in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $8.4 million, as compared to $7.2 million in the first quarter of 2015, representing an increase of $1.2 million. Research and development expense was unfavorable compared to the first quarter of 2015 principally as a result of the exclusion of 2015 research and development expense prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, research and development expense was largely unchanged from the first quarter of 2015.

### Operating Profit

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 | 2015 |
| --- | ---: | ---: |
| Operating profit | $52.1 | $2.2 |

Operating profit in the first quarter of 2016 totaled $52.1 million, or 6.3% of net sales, as compared to $2.2 million, or 0.4% of net sales, in the first quarter of 2015, representing an increase of $49.9 million.

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 $ Change |
| --- | ---: |
| Change, adjusted for acquisitions and foreign currency translation | $44.3 |
| - Acquisitions | 10.3 |
| - Foreign Currency Translation | (4.7) |
| Total Change | $49.9 |

For the three months ended March 31, 2016, adjusted for acquisitions and foreign currency translation, operating profit increased by $44.3 million.

Performance Solutions' operating profit in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $33.1 million, as compared to $33.3 million in the first quarter of 2015, representing a decrease of $0.2 million, or 0.6%.

Agricultural Solutions' operating profit (loss) in the first quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $57.5 million, as compared to $(2.0) million in the first quarter of 2015, representing an increase of $59.5 million. The first quarter of 2016 was favorable to the first quarter of 2015 largely as a result of the exclusion of 2015 expense activity prior to the Arysta Acquisition on February 13, 2015 and the impact of inventory purchase accounting in 2015 of $36.1 million. On a comparable basis, the operating profit increased due to favorable price changes and reductions in spending reflected in costs of sales and selling, technical, general and administrative expenses, partially offset by declines in sales volume during the three months ended March 31, 2016.

Partially offsetting the operating profits from the segments was additional investments made in building our corporate infrastructure in support of the demands driven by our substantial growth, including increases in headcount and professional fees, partially offset by lower quarter-over-quarter acquisition-related costs.

### Other (Expense) Income

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 | 2015 |
| --- | ---: | ---: |
| Interest expense, net | $(93.8) | $(39.4) |
| Loss on derivative contracts | (5.3) | — |
| Foreign exchange (loss) gain | (71.1) | 33.9 |
| Other income, net | $2.1 | $1.7 |
| Total other expense | $(168.1) | $(3.8) |

Net interest expense in the first quarter of 2016 totaled $93.8 million, as compared to $39.4 million in the first quarter of 2015, representing an increase of $54.4 million. The increase relates primarily to interest charges resulting from incremental debt facilities used to fund the Alent Acquisition, including the November 2015 Notes Offering, Alent U.S. Dollar Tranche B-3 Term Loans and Alent EURO Tranche C-2 Term Loans, as well as a full quarter's impact in 2016 of the interest expense related to the incremental debt facilities used to fund the Arysta Acquisition, compared to the first quarter of 2015, which, due to the date of this acquisition, included only a partial quarter's impact.

Loss on derivative contracts in the first quarter of 2016 totaled $5.3 million, as compared to zero in the first quarter of 2015. The increase of $5.3 million represents an increase in our use of foreign exchange and metals derivative contracts to better manage our market risks.

Foreign exchange loss in the first quarter of 2016 totaled $71.1 million, as compared to a gain of $33.9 million in the first quarter of 2015. The balance in the first quarter of 2016 includes $66.1 million of foreign exchange losses associated with the remeasurement of foreign denominated external and intercompany debt related to the Acquisitions, compared to a gain of $24.1 million in the first quarter 2015.

Other income, net in the first quarter of 2016 totaled $2.1 million, or 0.3% of net sales, as compared to $1.7 million in the first quarter of 2015, representing an increase of 0.4 million. Other income in 2015 included $3.0 million related to the expiration of an acquisition-related put option on our common stock in connection with the Agriphar Acquisition.

### Income Tax

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 | 2015 |
| --- | ---: | ---: |
| Income tax expense | $(18.4) | $(24.7) |
| Effective tax rate | (15.9)% | (1,547)% |

The income tax expense for the three months ended March 31, 2016 totaled $18.4 million, as compared to $24.7 million for the three months ended March 31, 2015. Our effective tax rate for the three months ended March 31, 2016 was (15.9)% on pre-tax losses of $116 million, compared to an effective tax rate of (1,547)% on pre-tax loss of $1.6 million for the three months ended March 31, 2015. The difference between the statutory and effective tax rate for the three months ended March 31, 2016 principally relates to the recognition of a $59.6 million valuation allowance on current quarter losses related to net operating losses that may not be recoverable for U.S. and foreign companies. The difference from the statutory to effective tax rates for the three months ended March 31, 2015 resulted principally from the establishment of a $19.0 million valuation allowance on foreign tax credit carryovers as a result of the impact of the Arysta Acquisition and losses that did not produce tax benefits.

### Liquidity and Capital Resources

In order to fund our acquisition activity, we have incurred substantial indebtedness totaling $5.26 billion as of March 31, 2016, with expected interest payments in excess of $300 million per year. Our first significant principal debt payments, totaling $3.23 billion and primarily representing principal payments at maturity associated with all of our outstanding term loans under our Amended and Restated Credit Agreement, are due in 2020. In addition, on April 20, 2017, we may also be required to repurchase each share of Series B Convertible Preferred Stock that has not been previously converted or automatically redeemed. The related potential cash obligation, which varies based on our stock price, corresponds to a maximum amount of $600 million.

As of March 31, 2016, this maximum potential obligation was approximately $410 million. We anticipate sufficient cash from operations to fund interest, working capital and other capital expenditures for the foreseeable future and have access to a $500 million line of credit under our Revolving Credit Facility, with current availability of $385 million, as well as availability under various lines of credit and overdraft facilities of $87.4 million. However, any settlement of the Series B Convertible Preferred Stock obligation, working capital shortfalls and future acquisitions may require utilization of our Revolving Credit Facility as well as proceeds from future debt and/or equity offerings. Our long-term liquidity may be impacted by our ability to borrow additional funds, renegotiate existing debt and/or raise equity under terms that are favorable to us.

Our primary sources of liquidity during the three months ended March 31, 2016 were borrowings under our Revolving Credit Facility and available cash. Our primary uses of cash and cash equivalents were raw material purchases, salary expenses, capital expenditures, debt service obligations and a business acquisition. We believe that our cash and cash equivalent balance and cash generated from operations will be sufficient to meet our working capital needs, capital expenditures and other business requirements for at least the next twelve months. Pending any future acquisitions, however, we may require additional borrowings against our Revolving Credit Facility as well as future debt and/or equity offerings. At March 31, 2016, we had $330 million in cash and cash equivalents in addition to availability under our lines of credit of $472 million.

Of our $330 million of cash and cash equivalents at March 31, 2016, $309 million was held by our foreign subsidiaries. The majority of the cash held by foreign subsidiaries is generally available for the ongoing needs of our operations. The laws of certain countries may limit our ability to utilize cash resources held in those countries for operations in other countries. However, these laws are not likely to impact our liquidity in a material way. The operations of each foreign subsidiary generally fund such subsidiary’s capital requirements. In the event that other foreign operations or operations within the United States require additional cash, we may transfer cash between and among subsidiaries as needed so long as such transfers are in accordance with law. As of March 31, 2016, we had the ability to repatriate $6.4 million at our discretion from the foreign subsidiaries and branches while the remaining balance of $303 million was held at subsidiaries in which earnings are considered permanently reinvested. Repatriation of some of these funds could be subject to delays and could have potential tax consequences, principally with respect to withholding taxes paid in foreign jurisdictions. If cash is repatriated from jurisdictions in which earnings are considered permanently reinvested we will be required to accrue and pay U.S. income taxes on such repatriations.

On January 31, 2016, the Company completed the OMG Malaysia Acquisition for approximately $124 million, net of acquired cash and closing working capital adjustments, subject to purchase price adjustments. The Company acquired OMG Malaysia to add-on to the OMG Acquisition and further enhance its Performance Solutions segment. See Note 2, *Acquisitions of Business,* for further detail.

We may from time to time seek to retire or purchase our outstanding debt, including, but not limited to, our Senior Notes, through cash purchases, exchanges for equity securities, or refinancing, in open market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.

The following is a summary of our cash flows provided by (used in) operating, investing and financing activities during the periods indicated:

*(amounts in millions)*

|  | Three Months Ended March 31, 2016 | 2015 (as restated (1)) |
| --- | ---: | ---: |
| **Cash and cash equivalents, beginning of the period** | **$432.2** | **$397.3** |
| Cash (used in) provided by operating activities | (210.4) | 2.8 |
| Cash used in investing activities | (19.9) | (2,291.1) |
| Cash provided by financing activities | 120.7 | 2,198.9 |
| Exchange rate impact on cash and cash equivalents | 7.1 | (10.6) |
| **Cash and cash equivalents, end of the period** | **$329.7** | **$297.3** |

(1) The Condensed Consolidated Statement of Cash Flows for the three months ended March 31, 2015 was restated as a result of an error related to the Arysta Acquisition. See Note 20, *Restatement of Unaudited Interim Condensed Consolidated Financial Statements*, to the unaudited interim Condensed Consolidated Financial Statements.

### Operating Activities

During the three months ended March 31, 2016, cash used in operating activities totaled $210.4 million. The net loss incurred during the period totaling $134 million was offset by $118 million in non-cash add-backs. The non-cash add-backs were largely related to depreciation and amortization of $82.6 million, foreign exchange losses on the 6.00% EUR Notes due 2023 of $18.0 million, the elimination of manufacturer’s profit in inventory in connection with our Acquisitions of $12.0 million, restructuring charges of $5.0 million, amortization of deferred financing fees of $4.7 million, impairment on an asset held for sale of $2.8 million and other miscellaneous non-cash add-backs of $7.4 million. These non-cash add-backs were partially offset by deferred income taxes of $14.2 million.

Changes in assets and liabilities, net of acquisitions, consumed 137.9 million more cash during the three months ended March 31, 2016 compared to the three month ended March 31, 2015. The major drivers of the unfavorable change in assets and liabilities were increases in inventory due in part to a stronger and earlier growing season in Europe and decreases in accounts payable.

### Investing Activities

Cash flows used in investing activities totaled $19.9 million during the three months ended March 31, 2016, as compared to $2.29 billion of cash flows used in investing activities for the same period in 2015. The decrease was primarily due to $2.86 billion of net cash outflows related primarily to the Arysta Acquisition during the three months ended March 31, 2015, which was partially offset by a release of $600 million in restricted cash for this acquisition, compared to $1.2 million of net cash outflows primarily related to the OMG Malaysia Acquisition for the same period during 2016. Additionally, we reduced capital expenditures and investments in product registration rights by an aggregate $10.1 million during the three months ended March 31, 2016 compared to the same period in 2015.

### Financing Activities

Cash flows provided by financing activities totaled $121 million during the three months ended March 31, 2016, as compared to $2.20 billion of cash flows provided by financing activities for the same period in 2015. The decrease was primarily due to proceeds of $2.08 billion from borrowings used to fund, in part, the Arysta Acquisition during the three months ended March 31, 2015. We borrowed $25.4 million less cash under our Revolving Credit Facility during the three months ended March 31, 2016 than during to the same period in 2015. Additionally, repayments of borrowings were $8.7 million and $3.6 million for the three months ended March 31, 2016 and 2015, respectively. Partially offsetting the decrease were payments of debt financing fees of $44.6 million associated with the borrowings made during the three months ended March 31, 2015, compared to insignificant payments of this kind for the same period in 2016.

### Financial Borrowings

### Credit Facilities

As of March 31, 2016, we had $5.26 billion of indebtedness, which included $1.96 billion of Senior Notes and $3.28 billion of term debt arrangements outstanding under our First Lien Credit Facility; $149 million of borrowings under revolver and overdraft lines of credit; and $10.7 million of stand-by letters of credit, which reduce the borrowings available under our Revolving Credit facility. Availability under our Revolving Credit Facility and various lines of credit and overdraft facilities totaled $472 million as of March 31, 2016.

#### Alent Acquisition

In connection with the Alent Acquisition, in November 2015, we completed the November 2015 Notes Offering of $500 million in aggregate principal amount of 10.375% USD Notes due 2021. The notes are governed by an indenture, dated November 10, 2015, as amended from time to time, bear interest at a rate of 10.375% and mature on May 1, 2021, unless earlier redeemed. In addition, we borrowed $1.05 billion under the Alent U.S. Dollar Tranche B-3 Term Loan (less original issue discount of 2%), €300 million under the Alent EURO Tranche C-2 Term Loan (less original issue discount of 2%), and $115 million under our multi-currency Revolving Credit Facility.

#### Arysta Acquisition

In connection with the Arysta Acquisition, in February 2015, we completed the February 2015 Notes Offering of $1.10 billion aggregate principal amount of 6.50% USD Notes due 2022, plus original issue premium of $1.0 million, and €350 million aggregate principal amount of 6.00% EUR Notes due 2023. The notes are governed by an indenture, dated February 2, 2015, as amended from time to time. The 6.50% USD Notes due 2022 and the 6.00% EUR Notes due 2023 mature on February 1, 2022 and February 1, 2023, respectively, unless earlier redeemed. The 6.50% USD Notes due 2022 and the 6.00% EUR Notes due 2023 bear interest at a rate of 6.50% and 6.00% per year, respectively, until maturity. In addition, we borrowed $500 million under the Arysta U.S. Dollar Tranche B-2 Term Loan (less original issue discount of 1%), €83.0 million under the Arysta EURO Tranche C-1 Term Loan (less original issue discount of 2%), and $160 million under our U.S. Dollar Revolving Credit Facility.

#### CAS Acquisition

In connection with the CAS Acquisition, in August 2014, we borrowed $130 million under the CAS U.S. Dollar Tranche B Term Loan, €205 million under the CAS EURO Tranche C-1 Term Loan, $60.0 million under our U.S. Dollar Revolving Credit Facility, and €55.0 million under our multicurrency Revolving Credit Facility.

#### Agriphar Acquisition

In connection with the Agriphar Acquisition, in October 2014, we borrowed $300 million under the USD Incremental Loan.

#### MacDermid Acquisition

In connection with the MacDermid Acquisition, in October 2013, under its First Lien Credit Agreement, MacDermid, with Platform as co-borrower, borrowed $373 million in connection with the repayment of the $360 million in principal on its then second lien credit facility.

Our Credit Facilities contain various covenants, including limitations on additional indebtedness, dividends and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions and dispositions. In addition, our Revolving Credit Facility requires compliance with certain financial covenants, including a first lien net leverage ratio of no greater than 6.25 to 1.0 of (x) consolidated indebtedness secured by a first lien minus unrestricted cash and cash equivalents of the borrowers and guarantors under the Amended and Restated Credit Agreement to (y) consolidated EBITDA for the four most recent fiscal quarters, subject to a right to cure. As of March 31, 2016, the Company was in compliance with the debt covenants contained in our Credit Facilities.

### Off-Balance Sheet Transactions

We use customary off-balance sheet arrangements, such as operating leases and letters of credit, to finance our business. As a result of ASU No. 2016-02, “*Leases,”* for fiscal years and interim periods beginning after December 15, 2018, we will be required to record lease liabilities and right-of-use assets for all of our qualifying operating leases that are currently treated as off-balance sheet transactions.

There are no other arrangements that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Recent Accounting Pronouncements

***Revenue From Contracts with Customers (Topic 606)*** - In April 2016, the FASB issued ASU 2016-10, "*Identifying Performance Obligations and Licensing.*" The amendments provide clarification on the implementation guidance defining when a good or service is separately identifiable from other promises in the contract and on contracts with licenses of intellectual property. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU.

***Compensation - Stock Compensation (Topic 718)*** - In March 2016, the FASB issued ASU 2016-09, "*Improvements to Employee Share-Based Payment Accounting.*" The amendments change the accounting treatment related to tax windfall and shortfalls associated with share-based awards. The amendments also eliminate the requirement for entities to estimate future forfeiture rates associated with share-based awards and stipulate the requirement that cash payments made by employers when directly withholding shares for tax-withholdings purposes should be classified as a financing activity in the statement of cash flows. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements.

***Revenue From Contracts with Customers (Topic 606)*** - In March 2016, the FASB issued ASU 2016-08, "*Principal versus Agent Considerations*." The amendments improve the operability and understandability of the implementation guidance on principal versus agent considerations. The guidance is effective for fiscal years and interim periods beginning after December 31, 2017 with early adoption permitted. The Company is evaluating the impact of this ASU.

***Investments - Equity Method and Joint Ventures (Topic 323)*** - In March 2016, the FASB issued ASU No. 2016-07, "*Simplifying the Transition to the Equity Method of Accounting.*" The amendments simplify transition accounting when the ownership level or degree of influence held in an investment qualifies that investment for equity method accounting. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016, with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements.

***Derivatives and Hedging (Topic 815)*** - In March 2016, the FASB issued ASU 2016-06, "*Contingent Put and Call Options in Debt Instruments (a consensus of the FASB Emerging ISsues Task Force)*." The ASU clarifies guidance around determining whether call or put options that can accelerate the repayment of principal on a debt instrument that are considered embedded derivatives in debt or hybrid instruments meet the "clearly and closely related" criterion for determining whether the embedded derivative is required to be separated from the host contract and account for separately as a derivative. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. Adoption is required on a modified retrospective basis. The Company is evaluating the impact of this ASU.

***Derivatives and Hedging (Topic 815)*** - In March 2016, the FASB issued ASU No. 2016-05, "*Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships (a consensus of the FASB Emerging Issues Task Force).*" The amendments stipulate that a change in the counterparty of a derivative instrument that has been designated as the hedging instrument under Topic 815 does not, in and of itself, require de-designation of that hedging relationship, provided that all other hedge accounting criteria continue to be met. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 and provides entities with the option to apply either a prospective or a modified retrospective approach. The Company does not expect this ASU to have a material impact on its financial statements.

***Leases (Topic 842)*** - In February 2016, the FASB issued ASU No. 2016-02, “*Leases.”* The updated guidance applies to capital (or finance) and operating leases, and requires lessees to recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. Lessees can make an accounting policy choice to not recognize right of use assets and lease liabilities for short-term leases (leases with a lease term of 12 months or less). The guidance is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. The Company continues to evaluate the impact of this ASU.

***Financial Instruments - Overall (Subtopic 825.10) -*** In January 2016, the FASB issued ASU No. 2016-1, “*Recognition and Measurement of Financial Assets and Financial Liabilities.”* This update addresses certain aspects of recognition, measurement, presentation, and disclosure of financial assets and liabilities. Provisions of this ASU include, among others, requiring the measurement of certain equity investments at fair value, with changes in value recognized in net income, and simplifying the impairment assessment of certain equity investments. The guidance is effective for fiscal years and interim periods beginning after December 15, 2017. Early adoption is only permitted for provisions related to the recognition of changes in fair value of financial liabilities. The Company does not expected this ASU to have a material impact on its financial statements.

***Revenue from Contracts with Customers (Topic 606)*** - In August 2015, the FASB issued ASU No. 2015-14, “*Deferral of the Effective Date,”* which defers the effective date of ASU No. 2014-09, “*Revenue from Contracts with Customers (Topic 606),"* for all entities by one year. As a result, the provisions of ASU No. 2014-09 will be effective prospectively for fiscal years and interim periods beginning after December 15, 2017. ASU No. 2014-09 (1) removes inconsistencies and weaknesses in revenue requirements, (2) provides a more robust framework for addressing revenue issues, (3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, (4) provides more useful information to users of financial statements through improved disclosure requirements, and (5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company continues to evaluate the impact of this ASU.

***Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)*** - In April 2015, the FASB issued ASU No. 2015-05, “*Customer's Accounting for Fees Paid in a Cloud Computing Arrangement.”* This update provides explicit guidance to customers utilizing a cloud computing solution to help determine whether such an arrangement includes a software license, in which case the accounting applied would be similar to that of other software license arrangements. Otherwise, the arrangement would be accounted for as a service contract. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements.

***Income Statement – Extraordinary and Unusual Items (Subtopic 225-20)*** - In January 2015, the FASB issued ASU No. 2015-1, “*Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.”* This update eliminates the requirement for entities to identify extraordinary events and transactions, those being both unusual in nature and infrequent in occurrence, and separately classify, present and disclose such items. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. The Company did not have any extraordinary or unusual income statement items recorded for any periods presented, therefore, this ASU did not have a material impact on the Company's financial statements.

***Presentation of Financial Statements - Going Concern (Subtopic 205-40)*** - In August 2014, the FASB issued ASU No. 2014-15, "*Disclosure of Uncertainties about and Entity’s Ability to Continue as a Going Concern."* The amendments provide clarification on conditions and events that should be considered by management at each annual and interim reporting period in determining whether there exists substantial doubt as to an entity’s ability to continue as a going concern. The guidance is effective for fiscal years and interim periods beginning after December 31, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements.

***Compensation – Stock Compensation (Topic 718)*** - In June 2014, the FASB issued ASU No. 2014-12, “*Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force).”* The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements as it had no share-based compensation awards that were effected by this pronouncement.

## Market risk

As filed, 325 characters.

The quantitative and qualitative disclosures about market risk required by this item have not changed materially from those disclosed in our Annual Report. For a discussion of our exposure to market risk, refer to Part II, Item 7A, "Quantitative and Qualitative Disclosures about Market Risk," contained in our Annual Report.

## Controls and procedures

As filed, 6,279 characters.

### (a) Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining disclosure controls and procedures as defined in Rules 13a-15 (e) and 15d-15(e) under the Exchange Act. As required by Rule 13a-15(b) of the Exchange Act, management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our CEO and CFO have concluded that the Company’s disclosure controls and procedures were not effective due to the material weaknesses in our internal control over financial reporting previously disclosed under Item 9A of our Annual Report.

The material weaknesses in our internal control relating to insufficient complement of personnel with an appropriate level of accounting knowledge, experience and training commensurate with our financial reporting requirements, which are described more fully in our Annual Report, continued to exist as of the end of the period covered by this Quarterly Report. These material weaknesses resulted to date in the restatement of the unaudited interim financial statements previously issued in our quarterly report on Form 10-Q for the quarter ended March 31, 2015 as a result of an error related to the Arysta Acquisition, as described in this Quarterly Report, and the restatement of income taxes in the unaudited interim financial statements previously issued in our quarterly report on Form 10-Q for the quarter ended September 30, 2015, as described in our Annual Report.

Our management is actively engaged in implementing the remediation initiatives described in our Annual Report which are designed to address these material weaknesses and, subsequent to the filing of our Annual Report, has specifically:

- started the implementation of a global consolidation and planning system, which is expected to be completed during the later half of 2016;
- implemented control processes as it relates to newly-acquired businesses and non-routine transactions;
- implemented enhanced monitoring controls relating to the financial reporting and performance of Platform's newly-acquired businesses;
- completed the implementation of a global tax reporting system;
- enhanced Platform's financial planning and analysis function within its businesses and at the corporate level;
- added further qualified resources to Platform's corporate and segment staff;
- enhanced the controllership function in Platform's newly-acquired businesses; and
- continued its recruiting efforts to hire qualified personnel.

While significant progress has been made, additional time is needed to fully implement and demonstrate the effectiveness of the remediation initiatives and until remediated, the material weaknesses described above could result in material misstatements of our annual or interim consolidated financial statements that would not be prevented or detected. The Company is committed to operating effective controls, and management continues to regularly assess the progress and sufficiency of the ongoing initiatives and make adjustments as and when necessary.

Notwithstanding the aforementioned material weaknesses, our management believes that such unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report fairly represent, in all material respects, our results of operations, financial position, and cash flows at and for the periods presented, each in accordance with U.S. GAAP. Based in part on these additional efforts, our CEO and CFO have included their certifications as exhibits to this Quarterly Report.

Our management has excluded from the evaluation of disclosure controls and procedures as of March 31, 2016 the internal control over financial reporting related to Alent, the OMG Businesses and OMG Malaysia because they were acquired by Platform in purchase business combinations consummated during the fourth quarter of 2015 with respect to Alent and the OMG Businesses and the first quarter of 2016 with respect to OMG Malaysia. Alent's, the OMG Businesses' and OMG Malaysia's total assets, excluding goodwill and intangible assets recognized in purchase accounting, and total revenues represent approximately 24% and 31%, respectively, of the related unaudited interim Condensed Consolidated Financial Statement amounts as of and for the quarter ended March 31, 2016. These acquisitions are material to our results of operations, financial condition and cash flows, and the integration following these business combinations is likely to materially impact the Company's internal control over financial reporting. We are in process of evaluating the internal controls over financial reporting for these acquisitions as required by the above stated Rules.

### (b) Changes to Internal Control Over Financial Reporting

As required by Rule 13a-15(d) under the Exchange Act, our management, including our CEO and CFO, has evaluated the Company’s internal control over financial reporting to determine whether any changes occurred during the quarter covered by this Quarterly Report have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

There have been no changes that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the quarter covered by this Quarterly Report.

## Risk factors

As filed, 4,336 characters.

Except as set forth below, there have been no material changes to the risk factors set forth in Part I, Item 1A of our Annual Report under the heading "Risk Factors."

***We have restated our unaudited interim condensed consolidated financial statements previously issued in our quarterly report on Form 10-Q for the quarter ended March 31, 2015.***

As further described in Note 20, *Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Unaudited)* to the unaudited interim Condensed Consolidated Financial Statements included herein, we previously disclosed in our quarterly report on Form 10-Q for the quarter ended June 30, 2015 an error to goodwill and foreign currency translation adjustment of $72.8 million relating to the Arysta Acquisition, which was corrected as an out-of-period adjustment in such quarterly report. We subsequently concluded that this previously disclosed error also had the effect of understating cash flows provided by operating activities and cash flows used in investing activities by $72.8 million and therefore further concluded that the previously reported information should no longer be relied upon. As a result, we restated our unaudited interim financial information for our first quarter ended March 31, 2015 in the aforementioned Note 20. If we are required to restate previously issued financial statements for any additional periods, our reputation could be impaired which could cause a loss of investor confidence and adversely materially affect our business, operating results and financial condition.

***Volatility of the trading prices of our common stock and/or Senior Notes could adversely affect our security holders.***

The trading prices of our common stock and Senior Notes have been highly volatile and could continue to be subject to wide fluctuations in response to various factors, some of which are beyond our control, including, but not limited to:

- quarterly variations in our operating results;
- changes in the market’s expectations about our operating results;
- our operating results failing to meet the expectation of management, securities analysts or investors in a particular period;
- the failure to remediate identified material weaknesses;
- changes in financial estimates and recommendations by securities analysts concerning our Company or our industry in general;
- operating and securities price performance of companies that investors deem comparable to us;
- news reports and publication of research reports relating to our business or trends in our markets;
- changes in laws and regulations affecting our businesses;
- announcements or strategic developments, acquisitions and other material events by us or our competitors;
- sales of substantial amounts of common stock by our directors, executive officers or significant stockholders or the perception that such sales could occur;
- adverse market reaction to any additional debt we incur in the future;
- litigation and class action proceedings;
- the failure to identify and complete acquisitions in the future or unexpected difficulties or developments related to the integration of recently completed, pending or future acquisitions;
- actions by institutional stockholders;
- general economic and political conditions such as recessions and acts of war or terrorism; and
- other matters discussed in this Quarterly Report.

In addition, the stock market in general, and the market for specialty chemicals companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors may seriously affect the market price of companies’ stock, including ours, regardless of actual operating performance. In addition, in the past, following periods of volatility in the overall market and the market price of particular companies’ securities, securities litigation and class action proceedings have often been instituted against such companies. A shareholder derivative action and a class action lawsuit of these types were filed against us in April and March 2016, respectively. There can be no assurance that the market price of our common stock and/or Senior Notes will not fall in the future due to any of the aforementioned factors.

Filed May 10, 2016.
Source: SEC EDGAR, the filing index for accession 0001590714-16-000153. Last ingested by Listed: Nov 10, 2026, 23:30 ET. No prices; not investment advice.
